<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0379-3982</journal-id>
<journal-title><![CDATA[Revista Tecnología en Marcha]]></journal-title>
<abbrev-journal-title><![CDATA[Tecnología en Marcha]]></abbrev-journal-title>
<issn>0379-3982</issn>
<publisher>
<publisher-name><![CDATA[Instituto Tecnológico de Costa Rica]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0379-39822020000400125</article-id>
<article-id pub-id-type="doi">10.18845/tm.v33i4.4653</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[C-ficocianinas: modulación del sistema inmune y su posible aplicación como terapia contra el cáncer]]></article-title>
<article-title xml:lang="en"><![CDATA[C-phycocyanins: immune system modulation and its possible application as therapy against cancer]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Alfaro-Alfaro]]></surname>
<given-names><![CDATA[Álvaro Esteban]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Alpízar-Cambronero]]></surname>
<given-names><![CDATA[Valerie]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Duarte-Rodríguez]]></surname>
<given-names><![CDATA[Ana Iris]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Feng-Feng]]></surname>
<given-names><![CDATA[Joana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rosales-Leiva]]></surname>
<given-names><![CDATA[Christopher]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mora-Román]]></surname>
<given-names><![CDATA[Juan José]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Costa Rica Facultad de Farmacia ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Costa Rica</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad de Costa Rica Facultad de Farmacia ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Costa Rica</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad de Costa Rica Facultad de Farmacia ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Costa Rica</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Universidad de Costa Rica Facultad de Farmacia ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Costa Rica</country>
</aff>
<aff id="Af5">
<institution><![CDATA[,Universidad de Costa Rica Facultad de Farmacia ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Costa Rica</country>
</aff>
<aff id="Af6">
<institution><![CDATA[,Universidad de Costa Rica Departamento de Farmacia Industrial Facultad de Farmacia]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Costa Rica</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2020</year>
</pub-date>
<volume>33</volume>
<numero>4</numero>
<fpage>125</fpage>
<lpage>139</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.sa.cr/scielo.php?script=sci_arttext&amp;pid=S0379-39822020000400125&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.sa.cr/scielo.php?script=sci_abstract&amp;pid=S0379-39822020000400125&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.sa.cr/scielo.php?script=sci_pdf&amp;pid=S0379-39822020000400125&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen El cáncer es una enfermedad compleja, heterogénea y dinámica, caracterizada por una mitosis descontrolada. Históricamente, se ha tratado con cirugía, radioterapia y quimioterapia, y en años más recientes mediante la inmunoterapia. Para ello, se han investigado distintas proteínas para la modulación de la respuesta inmune. Un grupo de estas son las C-ficocianinas, biliproteinas proveniente de microalgas verde azuladas como Spirulina platensis. El ambiente antiinflamatorio en personas sanas es una medida profiláctica para disminuir el riesgo de desarrollar un determinado tipo de cáncer. Su ingesta ha mostrado ese comportamiento, al suprimir la liberación de sustancias proinflamatorias. También se ha apreciado un efecto inmunomodulador al aumentar o disminuir la expresión de CD59, así como al ocasionar la proliferación de macrófagos y la liberación de sustancias inflamatorias. Esto último es un indicativo de que no se cuenta con información suficiente para corroborar su uso como opción profiláctica o terapéutica contra el cáncer. Por ello, es trascendental la información sobre sustancias naturales como estas, porque aunque se ven más atractivas para tratar dicha enfermedad, no existen efectos terapéuticos totalmente comprobados.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract Cancer is a complex, heterogeneous, and dynamic disease, characterized by uncontrolled mitosis. Historically, it has been treated with surgery, radiotherapy and chemotherapy, and immunotherapy in more recent years. For this, different proteins have been investigated for the modulation of the immune response. A group of these are C-phycocyanins, biliproteins from bluish-green microalgae such as Spirulina platensis. The anti-inflammatory environment in healthy people is a prophylactic measure to reduce the risk of developing a specific cancer type. Its intake has shown that behavior, by suppressing the release of pro-inflammatory substances. An immunomodulatory effect has also been appreciated by increasing or decreasing the expression of CD59, and causing the macrophage proliferation and the release of inflammatory substances. The latter is an indication that there is insufficient information to corroborate its use as a prophylactic or therapeutic option against cancer. Therefore, the information about natural substances such as these ones are transcendental, because although they are more attractive to treat said disease, there are no fully proven therapeutic effects.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Cáncer]]></kwd>
<kwd lng="es"><![CDATA[inmunoterapia]]></kwd>
<kwd lng="es"><![CDATA[C-ficocianina]]></kwd>
<kwd lng="es"><![CDATA[respuesta inmune]]></kwd>
<kwd lng="en"><![CDATA[Cancer]]></kwd>
<kwd lng="en"><![CDATA[immunotherapy]]></kwd>
<kwd lng="en"><![CDATA[C-phycocyanin]]></kwd>
<kwd lng="en"><![CDATA[immune response]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>(1)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moses]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[García-Bloj]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Harvey]]></surname>
<given-names><![CDATA[A. R.]]></given-names>
</name>
<name>
<surname><![CDATA[Blancafort]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hallmarks of cancer: The CRISPR generation]]></article-title>
<source><![CDATA[European Journal of Cancer]]></source>
<year>2018</year>
<numero>93</numero>
<issue>93</issue>
<page-range>10-8</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>(2)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bray]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Ferlay]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Soerjomataram]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Siegel]]></surname>
<given-names><![CDATA[R. L.]]></given-names>
</name>
<name>
<surname><![CDATA[Torre]]></surname>
<given-names><![CDATA[L. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Jemal]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries]]></article-title>
<source><![CDATA[CA: A Cancer Journal for Clinicians]]></source>
<year>2018</year>
<volume>68</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>394-424</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>(3)</label><nlm-citation citation-type="">
<collab>Ministerio de Salud</collab>
<source><![CDATA[Estadística de Cáncer - Registro Nacional Tumores.]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B4">
<label>(4)</label><nlm-citation citation-type="journal">
<collab>International Agency for Research on Cancer</collab>
<article-title xml:lang=""><![CDATA[World cancer factsheet]]></article-title>
<source><![CDATA[Cancer Research UK, Londres]]></source>
<year>2014</year>
</nlm-citation>
</ref>
<ref id="B5">
<label>(5)</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ramos Molina]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[&#8220;Obtención y Purificación de Ficocianinas Mediante Cromatografía de Adsorción en Lecho Expandido. Escalado del Proceso, Caracterización Fisicoquímica y Aplicación como Colorantes Naturales,&#8221;]]></source>
<year>2011</year>
</nlm-citation>
</ref>
<ref id="B6">
<label>(6)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schwabe]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bruggeman]]></surname>
<given-names><![CDATA[F. J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Contributions of Cell Growth and Biochemical Reactions to Nongenetic Variability of Cells]]></article-title>
<source><![CDATA[Biophysical Journal]]></source>
<year>2014</year>
<volume>107</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>301-13</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>(7)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Loeb]]></surname>
<given-names><![CDATA[L. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Loeb]]></surname>
<given-names><![CDATA[K. R.]]></given-names>
</name>
<name>
<surname><![CDATA[Anderson]]></surname>
<given-names><![CDATA[J. P.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Multiple mutations and cancer]]></article-title>
<source><![CDATA[Proceedings of the National Academy of Sciences of the United States of America]]></source>
<year>2003</year>
<volume>100</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>776-81</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>(8)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Boyer]]></surname>
<given-names><![CDATA[A. S.]]></given-names>
</name>
<name>
<surname><![CDATA[Walter]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Sørensen]]></surname>
<given-names><![CDATA[C. S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[DNA replication and cancer: From dysfunctional replication origin activities to therapeutic opportunities]]></article-title>
<source><![CDATA[Seminars in Cancer Biology]]></source>
<year>2016</year>
<page-range>37-8</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>(9)</label><nlm-citation citation-type="">
<collab>Organización Mundial de la Salud</collab>
<source><![CDATA[]]></source>
<year>2018</year>
</nlm-citation>
</ref>
<ref id="B10">
<label>(10)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[de la Peña-López]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Remolina-Bonilla]]></surname>
<given-names><![CDATA[Y. A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cáncer]]></article-title>
<source><![CDATA[Gaceta Médica De México]]></source>
<year>2016</year>
<volume>152</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>63-6</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>(11)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Parizadeh]]></surname>
<given-names><![CDATA[S. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Jafarzadeh-Esfehani]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Hassanian]]></surname>
<given-names><![CDATA[S. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Parizadeh]]></surname>
<given-names><![CDATA[S. M. R.]]></given-names>
</name>
<name>
<surname><![CDATA[Vojdani]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Ghandehari]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Targeting cancer stem cells as therapeutic approach in the treatment of colorectal cancer]]></article-title>
<source><![CDATA[The International Journal of Biochemistry and Cell Biology]]></source>
<year>2019</year>
<volume>110</volume>
<page-range>75-83</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>(12)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nasim]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Sabath]]></surname>
<given-names><![CDATA[B. F.]]></given-names>
</name>
<name>
<surname><![CDATA[Eapen]]></surname>
<given-names><![CDATA[G. A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lung Cancer]]></article-title>
<source><![CDATA[Medical Clinics of North America]]></source>
<year>2019</year>
<volume>103</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>463-73</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>(13)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hanahan]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Weinberg]]></surname>
<given-names><![CDATA[R. A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hallmarks of Cancer: The Next Generation,]]></article-title>
<source><![CDATA[Cell]]></source>
<year>2011</year>
<volume>144</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>646-74</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>(14)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodríguez Montero]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cáncer gástrico: Su relación con Helicobacter pylori]]></article-title>
<source><![CDATA[Revista Médica de Costa Rica y Centroamérica]]></source>
<year>2014</year>
<volume>71</volume>
<numero>609</numero>
<issue>609</issue>
<page-range>5-7</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>(15)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ghosh]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ghartimagar]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Thapa]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Oncogenes - the basics]]></article-title>
<source><![CDATA[Journal of Biomedical Sciences]]></source>
<year>2016</year>
<volume>3</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>35-7</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>(16)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[E. F.]]></given-names>
</name>
<name>
<surname><![CDATA[da Silva Figueira]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Lettnin]]></surname>
<given-names><![CDATA[A. P.]]></given-names>
</name>
<name>
<surname><![CDATA[Carrett-Dias]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Filgueira]]></surname>
<given-names><![CDATA[D. M. V. B.]]></given-names>
</name>
<name>
<surname><![CDATA[Kalil]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[C-Phycocyanin: Cellular targets, mechanisms of action and multi drug resistance in cancer]]></article-title>
<source><![CDATA[Pharmacological Reports]]></source>
<year>2017</year>
<volume>70</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>75-80</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>(17)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arthur]]></surname>
<given-names><![CDATA[J. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Perez-Chanona]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Mühlbauer]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Tomkovich]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Uronis]]></surname>
<given-names><![CDATA[J. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Fan]]></surname>
<given-names><![CDATA[T. J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota]]></article-title>
<source><![CDATA[Science]]></source>
<year>2012</year>
<volume>338</volume>
<numero>6103</numero>
<issue>6103</issue>
<page-range>120-3</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>(18)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Crusz]]></surname>
<given-names><![CDATA[S. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Balkwill]]></surname>
<given-names><![CDATA[F. R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Inflammation and cancer: advances and new agents]]></article-title>
<source><![CDATA[Nature Reviews Clinical Oncology]]></source>
<year>2015</year>
<volume>12</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>584-96</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>(19)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zitvogel]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Pietrocola]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Kroemer]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nutrition, inflammation and cancer]]></article-title>
<source><![CDATA[Nature Immunology]]></source>
<year>2017</year>
<volume>18</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>843-50</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>(20)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zamai]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Ponti]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Mirandola]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Gobbi]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Papa]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Galeotti]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[NK Cells and Cancer]]></article-title>
<source><![CDATA[The Journal of Immunology]]></source>
<year>2007</year>
<volume>178</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>4011</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>(21)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mahmoud]]></surname>
<given-names><![CDATA[S. M. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Paish]]></surname>
<given-names><![CDATA[E. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Powe]]></surname>
<given-names><![CDATA[D. G.]]></given-names>
</name>
<name>
<surname><![CDATA[Macmillan]]></surname>
<given-names><![CDATA[R. D.]]></given-names>
</name>
<name>
<surname><![CDATA[Grainge]]></surname>
<given-names><![CDATA[M. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[A. H. S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer]]></article-title>
<source><![CDATA[Journal of Clinical Oncology]]></source>
<year>2011</year>
<volume>29</volume>
<numero>15</numero>
<issue>15</issue>
<page-range>1949-55</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>(22)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hamanishi]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Mandai]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Iwasaki]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Okazaki]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Tanaka]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Yamaguchi]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer]]></article-title>
<source><![CDATA[Proceedings of the National Academy of Sciences of the United States od America]]></source>
<year>2007</year>
<volume>104</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>3360-5</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>(23)</label><nlm-citation citation-type="">
<collab>Instituto Nacional del Cáncer</collab>
<source><![CDATA[Tipos de tratamiento.]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B24">
<label>(24)</label><nlm-citation citation-type="">
<collab>Instituto Nacional del Cáncer</collab>
<source><![CDATA[Diccionario de cáncer.]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B25">
<label>(25)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stanculeanu]]></surname>
<given-names><![CDATA[D. L.]]></given-names>
</name>
<name>
<surname><![CDATA[Daniela]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Lazescu]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bunghez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Anghel]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Development of new immunotherapy treatments in different cancer types]]></article-title>
<source><![CDATA[Journal of Medicine and Life]]></source>
<year>2016</year>
<volume>9</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>240-8</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>(26)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arshad]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Baleanu]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Tang]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Al Qurashi]]></surname>
<given-names><![CDATA[M. M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dynamical analysis of fractional order model of immunogenic tumors]]></article-title>
<source><![CDATA[Advances in Mechanical Engineering]]></source>
<year>2016</year>
<volume>8</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1-13</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>(27)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fuge]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Vasdev]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Allchorne]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Green]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Immunotherapy for bladder cancer]]></article-title>
<source><![CDATA[Research and Reports in Urology]]></source>
<year>2015</year>
<volume>7</volume>
<page-range>65-79</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>(28)</label><nlm-citation citation-type="journal">
<collab>National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention</collab>
<article-title xml:lang=""><![CDATA[Eliminación de la TB, Vacuna BCG]]></article-title>
<source><![CDATA[Center for Disease Control and Prevention]]></source>
<year>2011</year>
</nlm-citation>
</ref>
<ref id="B29">
<label>(29)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[González Sánchez]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Armada Esmores]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Llópiz Casanova]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Propiedades de los interferones y su acción antitumoral]]></article-title>
<source><![CDATA[Medicentro Electrónica]]></source>
<year>2017</year>
<volume>21</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>192-8</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>(30)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tarhini]]></surname>
<given-names><![CDATA[A. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Gogas]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Kirkwood]]></surname>
<given-names><![CDATA[J. M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[IFN-&#945; in the Treatment of Melanoma]]></article-title>
<source><![CDATA[The Journal of Immunology]]></source>
<year>2012</year>
<volume>189</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>3789-93</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jiang]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Zhou]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Ren]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Role of IL-2 in cancer immunotherapy]]></article-title>
<source><![CDATA[Oncoimmunology]]></source>
<year>2016</year>
<volume>5</volume>
<numero>6</numero>
<edition>1163462</edition>
<issue>6</issue>
</nlm-citation>
</ref>
<ref id="B32">
<label>(32)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mata-Espinosa]]></surname>
<given-names><![CDATA[D. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández-Pando]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Interferón gamma: aspectos básicos, importancia clínica y usos terapéuticos]]></article-title>
<source><![CDATA[Revista de Investigación Clínica]]></source>
<year>2008</year>
<volume>60</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>421-31</page-range></nlm-citation>
</ref>
<ref id="B33">
<label>(33)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fragoso]]></surname>
<given-names><![CDATA[J. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Vargas Alarcón]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Jiménez Morales]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Reyes Hernández]]></surname>
<given-names><![CDATA[O. D.]]></given-names>
</name>
<name>
<surname><![CDATA[Ramírez Bello]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[El factor de necrosis tumoral &#945; (TNF-&#945;) en las enfermedades autoinmunes (EA): biología molecular y genética]]></article-title>
<source><![CDATA[Gaceta Médica de México]]></source>
<year>2014</year>
<volume>150</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>334-44</page-range></nlm-citation>
</ref>
<ref id="B34">
<label>(34)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bermúdez-Morales]]></surname>
<given-names><![CDATA[V. H.]]></given-names>
</name>
<name>
<surname><![CDATA[Peralta-Zaragoza]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Madrid-Marina]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Terapia génica con citocinas contra cáncer cervicouterino]]></article-title>
<source><![CDATA[Salud Pública de México]]></source>
<year>2005</year>
<volume>47</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>458-68</page-range></nlm-citation>
</ref>
<ref id="B35">
<label>(35)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chinen]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Kannan]]></surname>
<given-names><![CDATA[A. K.]]></given-names>
</name>
<name>
<surname><![CDATA[Levine]]></surname>
<given-names><![CDATA[A. G]]></given-names>
</name>
<name>
<surname><![CDATA[Fan]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Klein]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Zheng]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[An essential role for the IL-2 receptor in Treg cell function]]></article-title>
<source><![CDATA[Nature Immunology]]></source>
<year>2016</year>
<volume>17</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1322-33</page-range></nlm-citation>
</ref>
<ref id="B36">
<label>36</label><nlm-citation citation-type="">
<collab>Chemocare</collab>
<source><![CDATA[Chemocare.]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B37">
<label>(37)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ferriols Lisart]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Ferriols Lisart]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Colomina Rodríguez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Inmunoterapia Tumoral. Vacunas y Terapia Génica]]></article-title>
<source><![CDATA[Farmacia Hospitalaria]]></source>
<year>1997</year>
<volume>21</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>166-70</page-range></nlm-citation>
</ref>
<ref id="B38">
<label>(38)</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[de Prado Hidalgo]]></surname>
<given-names><![CDATA[M. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Llanos Méndez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Seguridad y eficacia de los virus oncolíticos en el cáncer avanzado]]></source>
<year></year>
<page-range>2-3</page-range></nlm-citation>
</ref>
<ref id="B39">
<label>(39)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lerma]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Virus oncolíticos: un nuevo aliado en la lucha contra el cáncer,]]></article-title>
<source><![CDATA[Sociedad Española de Bioquímica y Biología Molecular]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B40">
<label>(40)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Köhler]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Derivation and Diversification of Monoclonal Antibodies,]]></article-title>
<source><![CDATA[Physiology or Medicine]]></source>
<year>1984</year>
<page-range>228-43</page-range></nlm-citation>
</ref>
<ref id="B41">
<label>(41)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dávila González]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Generalidades del tratamiento con anticuerpos monoclonales]]></article-title>
<source><![CDATA[Monografías de Archivos de Bronconeumología]]></source>
<year>2017</year>
<volume>4</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B42">
<label>(42)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Falero]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[B. L.]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Suzarte]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Otero]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Núñez]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Generación de hibridomas productores de anticuerpos monoclonales contra la proteína de membrana externa U (OmpU) de Vibrio cholerae]]></article-title>
<source><![CDATA[Revista CENIC Ciencias Biológicas]]></source>
<year>2006</year>
<volume>38</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>224-7</page-range></nlm-citation>
</ref>
<ref id="B43">
<label>(43)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Escrivá-de-Romaní]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Arumí]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bellet]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Saura]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[HER2-positive breast cancer: Current and new therapeutic strategies]]></article-title>
<source><![CDATA[The Breast]]></source>
<year>2018</year>
<volume>39</volume>
<page-range>80-8</page-range></nlm-citation>
</ref>
<ref id="B44">
<label>(44)</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vu]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Claret]]></surname>
<given-names><![CDATA[F. X.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Trastuzumab: Updated Mechanisms of Action and Resistance in Breast Cancer,]]></article-title>
<source><![CDATA[Frontiers in Oncology]]></source>
<year>2012</year>
<volume>2</volume>
<numero>62</numero>
<issue>62</issue>
</nlm-citation>
</ref>
<ref id="B45">
<label>(45)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Muthuswamy]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Pitteroff]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Gingrich]]></surname>
<given-names><![CDATA[J. R.]]></given-names>
</name>
<name>
<surname><![CDATA[Kalinski]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Combination of IFN&#945; and poly-I:C reprograms bladder cancer microenvironment for enhanced CTL attraction]]></article-title>
<source><![CDATA[Journal for ImmunoTherapy of Cancer]]></source>
<year>2015</year>
<volume>3</volume>
<numero>6</numero>
<issue>6</issue>
</nlm-citation>
</ref>
<ref id="B46">
<label>(46)</label><nlm-citation citation-type="">
<collab>Cancer.net.</collab>
<source><![CDATA[Qué es la inmunoterapia]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B47">
<label>(47)</label><nlm-citation citation-type="">
<collab>Instituto Nacional del Cáncer</collab>
<source><![CDATA[La terapia con células T y CAR ha sido aprobada para algunos niños y adultos jóvenes con leucemia.]]></source>
<year>2017</year>
</nlm-citation>
</ref>
<ref id="B48">
<label>(48)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gato]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Liechtenstein]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Blanco-Luquín]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Zudaire]]></surname>
<given-names><![CDATA[M. I.]]></given-names>
</name>
<name>
<surname><![CDATA[Kochan]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Escors]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Inmunoterapia genética con células dendríticas para el tratamiento del cáncer]]></article-title>
<source><![CDATA[Anales del Sistema Sanitario de Navarra]]></source>
<year>2015</year>
<volume>38</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>279-88</page-range></nlm-citation>
</ref>
<ref id="B49">
<label>(49)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kannaujiya]]></surname>
<given-names><![CDATA[V. K.]]></given-names>
</name>
<name>
<surname><![CDATA[Kumar]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Pathak]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Sinha]]></surname>
<given-names><![CDATA[R. P.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Phycobiliproteins and Their Commercial Significance]]></article-title>
<source><![CDATA[Cyanobacteria: From Basic Science to Applications,]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B50">
<label>(50)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[J. Wu]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[Y. T.]]></given-names>
</name>
<name>
<surname><![CDATA[P. Li]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Biosynthesis of Fluorescent &#946; Subunits of C-Phycocyanin from Spirulina subsalsa in Escherichia coli, and Their Antioxidant Properties]]></article-title>
<source><![CDATA[Molecules]]></source>
<year>2018</year>
<volume>23</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1369</page-range></nlm-citation>
</ref>
<ref id="B51">
<label>(51)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Manirafasha]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Ndikubwimana]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Zeng]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Lu]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Jing]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Phycobiliprotein: &#8220;Phycobiliprotein: Potential microalgae derived pharmaceutical and biological reagent]]></article-title>
<source><![CDATA[Biochemical Engineering Journal]]></source>
<year>2016</year>
<volume>109</volume>
<page-range>282-96</page-range></nlm-citation>
</ref>
<ref id="B52">
<label>(52)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fernández-Rojas]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández-Juárez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Pedraza-Chaverri]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nutraceutical properties of phycocyanin,]]></article-title>
<source><![CDATA[Journal of Functional Foods]]></source>
<year>2014</year>
<volume>11</volume>
<page-range>375-92</page-range></nlm-citation>
</ref>
<ref id="B53">
<label>(53)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[X. Q.]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[L. N.]]></given-names>
</name>
<name>
<surname><![CDATA[Chang]]></surname>
<given-names><![CDATA[W. R.]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[J. P.]]></given-names>
</name>
<name>
<surname><![CDATA[Gui]]></surname>
<given-names><![CDATA[L. L.]]></given-names>
</name>
<name>
<surname><![CDATA[Guo]]></surname>
<given-names><![CDATA[B. J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Structure of C-phycocyanin from Spirulina platensis at 2.2 Å resolution: a novel monoclinic crystal form for phycobiliproteins in phycobilisomes,]]></article-title>
<source><![CDATA[Acta Crystallographica Section D Biological crystallography]]></source>
<year>2001</year>
<volume>57</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>784-92</page-range></nlm-citation>
</ref>
<ref id="B54">
<label>(54)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Eriksen]]></surname>
<given-names><![CDATA[N. T.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Production of phycocyanin - a pigment with applications in biology, biotechnology, foods and medicine]]></article-title>
<source><![CDATA[Applied Microbiology Biotechnology]]></source>
<year>2008</year>
<volume>80</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-14</page-range></nlm-citation>
</ref>
<ref id="B55">
<label>(55)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kuddus]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Singh]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Thomas]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Al-Hazimi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Recent Developments in Production and Biotechnological Applications of C-Phycocyanin]]></article-title>
<source><![CDATA[BioMed Research International]]></source>
<year>2013</year>
<volume>742859</volume>
</nlm-citation>
</ref>
<ref id="B56">
<label>(56)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nemoto-Kawamura]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Hirahashi]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Nagai]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Yamada]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Katoh]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Hayashi]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Phycocyanin enhances secretary IgA antibody response and suppresses allergic IgE antibody response in mice immunized with antigen-entrapped biodegradable microparticles]]></article-title>
<source><![CDATA[Journal of Nutritional Science and Vitaminology]]></source>
<year>2004</year>
<volume>50</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>129-36</page-range></nlm-citation>
</ref>
<ref id="B57">
<label>(57)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Cai]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Cai]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medical Application of Spirulina platensis Derived C-Phycocianin]]></article-title>
<source><![CDATA[Evidence-Based Complementary and Alternative Medicine]]></source>
<year>2016</year>
<volume>7803846</volume>
</nlm-citation>
</ref>
<ref id="B58">
<label>(58)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Díaz Domínguez]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Marsán Suárez]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
<name>
<surname><![CDATA[del Valle Pérez]]></surname>
<given-names><![CDATA[L. O.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Principales propiedades inmunomoduladoras y antinflamatorias de la ficobiliproteína C-ficocianina]]></article-title>
<source><![CDATA[Revista Cubana de Hematología, Inmunología y Hemoterapia]]></source>
<year>2016</year>
<volume>32</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>447-54</page-range></nlm-citation>
</ref>
<ref id="B59">
<label>(59)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Romay]]></surname>
<given-names><![CDATA[Ch]]></given-names>
</name>
<name>
<surname><![CDATA[Gonzalez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Ledon]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Remirez]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Rimbau]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[C-Phycocyanin: A Biliprotein with Antioxidant, Anti-Inflammatory and Neuroprotective Effects]]></article-title>
<source><![CDATA[Current Protein and Peptide Science]]></source>
<year>2003</year>
<volume>4</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>207-16</page-range></nlm-citation>
</ref>
<ref id="B60">
<label>(60)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Agarwal]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Reddy]]></surname>
<given-names><![CDATA[G. V.]]></given-names>
</name>
<name>
<surname><![CDATA[Reddanna]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Eicosanoids in inflammation and cancer: the role of COX-2,]]></article-title>
<source><![CDATA[Expert Review of Clinical Immunology]]></source>
<year>2009</year>
<volume>5</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>145-65</page-range></nlm-citation>
</ref>
<ref id="B61">
<label>(61)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ding]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Feng]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Xu]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ding]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Asociación entre los polimorfismos de genes de mieloperoxidasa y la susceptibilidad a cáncer de próstata: un estudio caso-control en la población de nacionalidad china]]></article-title>
<source><![CDATA[Actas Urológicas Españolas]]></source>
<year>2013</year>
<volume>37</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>79-82</page-range></nlm-citation>
</ref>
<ref id="B62">
<label>(62)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Soni]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Dubey]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Verma]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Dhankhar]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Kaushal]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Revisiting the Role of Phycocyanin in Current Clinical Practice]]></article-title>
<source><![CDATA[International Journal of Pharmaceutical Sciences and Research]]></source>
<year>2015</year>
<volume>6</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>4588-600</page-range></nlm-citation>
</ref>
<ref id="B63">
<label>(63)</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Raja]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Hemaiswarya]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<source><![CDATA[&#8220;Microalgae and Immune Potential&#8221;]]></source>
<year>2010</year>
<publisher-loc><![CDATA[Nueva Jersey ]]></publisher-loc>
<publisher-name><![CDATA[Humana Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B64">
<label>(64)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[H. W.]]></given-names>
</name>
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[T. S.]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[M. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Chang]]></surname>
<given-names><![CDATA[Y. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Eugene]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Purification and immunomodulating activity of C-phycocyanin from Spirulina platensis cultured using power plant flue gas]]></article-title>
<source><![CDATA[Process Biochemistry]]></source>
<year>2014</year>
<volume>49</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1337-44</page-range></nlm-citation>
</ref>
<ref id="B65">
<label>(65)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jiang]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Yin]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Phycocyanin: A Potential Drug for Cancer Treatment]]></article-title>
<source><![CDATA[Journal of Cancer]]></source>
<year>2017</year>
<volume>8</volume>
<numero>17</numero>
<issue>17</issue>
<page-range>3416-29</page-range></nlm-citation>
</ref>
<ref id="B66">
<label>(66)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Gao]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Carter]]></surname>
<given-names><![CDATA[C. L.]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[Z. R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The recombinant &#946; subunit of C-phycocyanin inhibits cell proliferation and induces apoptosis]]></article-title>
<source><![CDATA[Cancer letters]]></source>
<year>2007</year>
<volume>247</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>150-8</page-range></nlm-citation>
</ref>
<ref id="B67">
<label>67</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Viñas Domínguez]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Enfermedades de tubulinas]]></article-title>
<source><![CDATA[Universidad de Cantabria, Cantabria, España]]></source>
<year>2016</year>
</nlm-citation>
</ref>
<ref id="B68">
<label>(68)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Iddar]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Valverde]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Assobhei]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Serrano]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Soukri]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Widespread occurrence of non-phosphorylating glyceraldehyde-3-phosphate dehydrogenase among gram-positive bacteria]]></article-title>
<source><![CDATA[International Microbiology]]></source>
<year>2005</year>
<volume>8</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>252-8</page-range></nlm-citation>
</ref>
<ref id="B69">
<label>(69)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Esparza-Jiménez Morán]]></surname>
<given-names><![CDATA[M. M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Calpaínas]]></article-title>
<source><![CDATA[Revista Médica MD]]></source>
<year></year>
<volume>1</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B70">
<label>(70)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Díaz Horta]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[El ion calcio: su regulación y función en la célula ß pancreática]]></article-title>
<source><![CDATA[Revista Cubana de Endocrinología]]></source>
<year>2003</year>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B71">
<label>(71)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Saini]]></surname>
<given-names><![CDATA[M. K.]]></given-names>
</name>
<name>
<surname><![CDATA[Sanyal]]></surname>
<given-names><![CDATA[S. N.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Piroxicam and c-phycocyanin prevent colon carcinogenesis by inhibition of membrane fluidity and canonical Wnt/&#946;-catenin signaling while up-regulating ligand dependent transcription factor PPAR&#947;]]></article-title>
<source><![CDATA[Biomedicine &amp; Pharmacotherapy]]></source>
<year>2014</year>
<volume>68</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>537-50</page-range></nlm-citation>
</ref>
<ref id="B72">
<label>(72)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Saini]]></surname>
<given-names><![CDATA[M. K.]]></given-names>
</name>
<name>
<surname><![CDATA[Sanyal]]></surname>
<given-names><![CDATA[S. N.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Targeting angiogenic pathway for chemoprevention of experimental colon cancer using C-phycocyanin as cyclooxygenase-2 inhibitor]]></article-title>
<source><![CDATA[Biochemistry and Cell Biology]]></source>
<year>2014</year>
<volume>92</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>206-18</page-range></nlm-citation>
</ref>
<ref id="B73">
<label>(73)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fernandes e Silva]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Figueira]]></surname>
<given-names><![CDATA[F. S.]]></given-names>
</name>
<name>
<surname><![CDATA[Cañedo]]></surname>
<given-names><![CDATA[A. D]]></given-names>
</name>
<name>
<surname><![CDATA[Machado]]></surname>
<given-names><![CDATA[K. S.]]></given-names>
</name>
<name>
<surname><![CDATA[Salgado]]></surname>
<given-names><![CDATA[M. T. S. F.]]></given-names>
</name>
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[T. K.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[C-phycocyanin to overcome the multidrug resistance phenotype in human erythroleukemias with or without interaction with ABC transporters]]></article-title>
<source><![CDATA[Biomedicine &amp; Pharmacotherapy]]></source>
<year>2018</year>
<volume>106</volume>
<page-range>532-42</page-range></nlm-citation>
</ref>
<ref id="B74">
<label>(74)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pentón-Rol]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Marín-Prida]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Falcón-Cama]]></surname>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[C-Phycocyanin and Phycocyanobilin as Remyelination Therapies for Enhancing Recovery in Multiple Sclerosis and Ischemic Stroke: A Preclinical Perspective]]></article-title>
<source><![CDATA[Behavioral Sciences]]></source>
<year>2018</year>
<volume>8</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B75">
<label>(75)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gdara]]></surname>
<given-names><![CDATA[N. B.]]></given-names>
</name>
<name>
<surname><![CDATA[Belgacem]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Khemiri]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Mannai]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Bitri]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Protective effects of phycocyanin on ischemia/ reperfusion liver injuries]]></article-title>
<source><![CDATA[Biomedicine &amp; Pharmacotherapy]]></source>
<year>2018</year>
<volume>102</volume>
<page-range>196-202</page-range></nlm-citation>
</ref>
<ref id="B76">
<label>(76)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ichimura]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Kato]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Tsuneyama]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Matsutake]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Kamogawa]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Hirao]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Phycocyanin prevents hypertension and low serum adiponectin level in a rat model of metabolic syndrome]]></article-title>
<source><![CDATA[Nutrition Research]]></source>
<year>2013</year>
<volume>33</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>397-405</page-range></nlm-citation>
</ref>
<ref id="B77">
<label>(77)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Ma]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Zheng]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Inhibition of islet amyloid polypeptide fibril formation by selenium-containing phycocyanin and prevention of beta cell apoptosis]]></article-title>
<source><![CDATA[Biomaterials]]></source>
<year>2014</year>
<volume>35</volume>
<numero>30</numero>
<issue>30</issue>
<page-range>8596-604</page-range></nlm-citation>
</ref>
<ref id="B78">
<label>(78)</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fayyad]]></surname>
<given-names><![CDATA[R. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Ali]]></surname>
<given-names><![CDATA[A. N. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Dwaish]]></surname>
<given-names><![CDATA[A. S.]]></given-names>
</name>
<name>
<surname><![CDATA[Al-Abboodi]]></surname>
<given-names><![CDATA[A. K. A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Anticancer Activity of Spirulina platensis Methanolic Extracts Against L20B and MCF7 Human Cancer Cell Lines]]></article-title>
<source><![CDATA[Plant Archives]]></source>
<year>2019</year>
<volume>19</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>1419-26</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
